Development of Azithromycin-PLGA Nanoparticles for Enhanced Antibacterial Activity

Strategic Insights -

Scientists at Tabriz University of Medical Sciences have successfully formulated azithromycin-loaded poly(lactide-co-glycolide) (PLGA) nanoparticles with improved physicochemical properties and enhanced antimicrobial activity against Salmonella typhi. The researchers employed the nanoprecipitation technique to prepare the nanoparticles in three different ratios of drug to polymer, which significantly affected the physicochemical properties. The nanoparticles exhibited a nanoscale size range of 212 to 252 nm, with the highest entrapment efficiency of 78.5% obtained at a 1:3 drug to polymer ratio. The results of the antimicrobial activity test showed that the nanoparticles were more effective than pure azithromycin against S. typhi, with an equal antibacterial effect at 1/8 concentration of the intact drug.

Key Takeaways:

  • The study aimed to develop azithromycin-loaded PLGA nanoparticles with improved physicochemical properties and enhanced antimicrobial activity against Salmonella typhi.
  • The researchers employed the nanoprecipitation technique to prepare the nanoparticles in three different ratios of drug to polymer.
  • The nanoparticles exhibited a nanoscale size range of 212 to 252 nm, with the highest entrapment efficiency of 78.5% obtained at a 1:3 drug to polymer ratio.
  • The DSC thermograms and X-ray diffraction patterns revealed that the drug in the nanoparticles was in an amorphous state.
  • FT-IR spectroscopy demonstrated no detectable interactions between the drug and polymer at the molecular level.
  • The in vitro release study showed a two-phase release pattern, with an initial burst for 4h followed by a slow release pattern during a period of 24h.
  • The antimicrobial activity test showed that the nanoparticles were more effective than pure azithromycin against Salmonella typhi.
  • The study concluded that the azithromycin nanoparticle preparations showed improved physicochemical and antimicrobial properties, making them suitable for oral administration.

Statistics:

  • The nanoparticles had a size range of 212 to 252 nm.
  • The highest entrapment efficiency of 78.5% was obtained at a 1:3 drug to polymer ratio.
  • The zeta potential of the nanoparticles was fairly negative.
  • The antimicrobial activity test showed that the nanoparticles were effective against Salmonella typhi at 1/8 concentration of the intact drug.
  • The in vitro release study showed a two-phase release pattern, with an initial burst for 4h followed by a slow release pattern during a period of 24h.

Sources:

  • Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi. Colloids and Surfaces B, Biointerfaces, 2010;80(1):34-9.
  • Nanotechnology - Nanoparticles.